AI in Healthcare October 8, 2024
As 2024 winds down and the number of FDA-approved medical devices packing AI approaches 1,000—the agency had the tally at 950 as of August—the industry finds itself at a “critical inflection point.”
Bessemer Venture Partners made the observation in a report they issued late last month, “Roadmap: Healthcare AI.” (AIin.Healthcare briefly noted the report’s release last week.)
“Today,” the Bessemer authors write, “each new breakthrough in research has the potential to solve real-world problems—an opportunity that should galvanize [AI startup] founders and investors to engage more deeply with emerging developments in the field.”
After describing some of the particulars inherent to the opportunities, Bessemer turns its attention to some challenges. Here are excerpts from the latter section.
...Today's Sponsors
Today's Sponsor